Hi,
FDA cant dispute a compelling ARDS trial.
Not with maybe 500,000 Americans getting put to the sword
in the next few months.
I dont see any end to this .At present there's only 1 in 400
thats infected. Unfortunately that has a lot more scope to
increase.
SI wants an approval plain and simple.
Aloha.
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-305
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |